ZJYL JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Feb 10, 2026
$1.94
· of 52w range
· above low
· to high
$1.5352w low
$12.0052w high
Market Cap
$304M
P/E
194.0
EPS
$0.01
Revenue
$21M
your badges
52W Range
$2–$12
Analyst Rating
·
Price Target
·
P/E
194.0
ROE
4.1%
Net Profit Margin
5.8%
Your badge strip is empty — pin a metric anywhere on this page.
ZJYL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.94
Market Cap
$304M
P/E
194.0
EPS
$0.01
Revenue
$21M
ROE
4.1%
Debt/Equity
0.6
52W Range
$2–$12
ZJYL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| March 16, 2026 | 1-for-20 | Reverse |
| Feb. 8, 2024 | 20-for-1 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$21M2021-09-30 → 2025-09-30
EPS$0.012021-09-30 → 2025-09-30
Free Cash Flow$-4M2023-09-30 → 2025-09-30
Net margin5.8%2023-09-30 → 2025-09-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ZJYL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 194.05Y avg ≈83.2 | ≈83.2 | · | · | |
| P/S | 14.75Y avg ≈10.5 | ≈10.5 | · | · | |
| P/B | 10.25Y avg ≈8.4 | ≈8.4 | · | · | |
| EV / EBITDA | 344.0 | · | · | · | |
| Price / FCF | -81.55Y avg ≈-91.4 | ≈-91.4 | · | · | |
| Price / Cash Flow | 104.65Y avg ≈-86.5 | ≈-86.5 | · | · | |
| EV / Revenue | 14.2 | · | · | · | |
| EV / FCF | -78.6 | · | · | · | |
| Price / Tangible Book | 10.65Y avg ≈8.7 | ≈8.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ZJYL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 29.2%5Y avg ≈34.6% | ≈34.6% | · | · | |
| Operating Margin | 2.9%5Y avg ≈11.0% | ≈11.0% | · | · | |
| EBITDA Margin | 4.1%5Y avg ≈12.1% | ≈12.1% | · | · | |
| Pretax Margin | 7.7%5Y avg ≈13.9% | ≈13.9% | · | · | |
| Net Profit Margin | 5.8%5Y avg ≈12.0% | ≈12.0% | · | · | |
| ROA | 2.4%5Y avg ≈7.5% | ≈7.5% | · | · | |
| ROE | 4.1%5Y avg ≈10.9% | ≈10.9% | · | · | |
| ROIC | 1.1%5Y avg ≈6.4% | ≈6.4% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ZJYL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.6 | · | · | · | |
| Current Ratio | 1.95Y avg ≈2.6 | ≈2.6 | · | · | |
| Quick Ratio | 1.55Y avg ≈1.6 | ≈1.6 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ZJYL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.6 | ≈0.6 | · | · | |
| Inventory Turnover | 2.95Y avg ≈2.6 | ≈2.6 | · | · | |
| Receivables Turnover | 3.55Y avg ≈4.7 | ≈4.7 | · | · | |
| Revenue / Employee | ≈$75.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $21M | $24M | $20M | $19M | |
| Cost of Revenue | $14M | $14M | $13M | $13M | |
| Gross Profit | $6M | $10M | $7M | $6M | |
| R&D Expense | $2M | $1M | $2M | $2M | |
| SG&A Expense | $3M | $3M | $2M | $2M | |
| Operating Expenses | $5M | $6M | $4M | $4M | |
| Operating Income | $608.2K | $4M | $3M | $2M | |
| Interest Income | $878.7K | $678.4K | $117.2K | $107.5K | |
| Other Non-op | $987.6K | $545.0K | $354.7K | $612.1K | |
| Pretax Income | $2M | $4M | $3M | $3M | |
| Income Tax | $214.6K | $763.9K | $343.7K | $36.1K | |
| Net Income | $1M | $4M | $3M | $3M | |
| EPS (Basic) | $0.01 | $0.02 | $0.02 | $0.02 | |
| EPS (Diluted) | $0.01 | $0.02 | $0.02 | $0.02 | |
| Shares (Basic) | 156,547,100 | 156,474,149 | 145,136,980 | 135,000,000 | |
| Shares (Diluted) | 156,547,100 | 156,474,149 | 145,136,980 | 135,000,000 | |
| EBITDA | $851.6K | $4M | $3M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $8M | $7M | · | |
| Short-term Investments | $22M | $19M | $10M | $2M | |
| Receivables | $6M | $6M | $3M | $4M | |
| Inventory | $5M | $5M | $5M | $7M | |
| Prepaid Expense | $4M | $2M | $892.6K | $989.3K | |
| Current Assets | $44M | $43M | $31M | $19M | |
| PP&E (Net) | $8M | $1M | $1M | $2M | |
| PP&E (Gross) | $12M | $6M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | |
| Intangibles | $1M | $1M | $154.4K | · | |
| Total Assets | $53M | $46M | $33M | $21M | |
| Accounts Payable | $3M | $3M | $3M | $4M | |
| Short-term Debt | $19M | $11M | $4M | · | |
| Current Liabilities | $24M | $17M | $9M | $6M | |
| Capital Leases | · | $96.2K | · | · | |
| Total Liabilities | $24M | $17M | $9M | $6M | |
| Total Debt | $19M | $11M | · | · | |
| Common Stock | $7.8K | $7.8K | $7.8K | $6.8K | |
| Paid-in Capital | · | $7M | $6M | $79.8K | |
| Retained Earnings | $21M | $20M | $17M | $14M | |
| AOCI | $-924.0K | $-556.2K | $-1M | $-911.1K | |
| Stockholders' Equity | $30M | $29M | $24M | $15M | |
| Liabilities + Equity | $53M | $46M | $33M | $21M | |
| Shares Outstanding | 156,547,100 | 155,947,100 | 155,947,100 | 135,000,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $243.4K | $237.8K | $225.9K | $362.6K | |
| Deferred Tax | $-22.1K | $36.3K | $89.6K | $-86.0K | |
| Other Non-cash | $1M | $-5M | $-87.3K | · | |
| Operating Cash Flow | $3M | $-1M | $3M | $2M | |
| CapEx | $7M | $144.9K | $113.9K | $40.2K | |
| Investing Cash Flow | $-11M | $-10M | $-8M | $-120.9K | |
| Stock Issued | · | $312.0K | · | · | |
| Net Stock Activity | · | $312.0K | · | · | |
| Financing Cash Flow | $7M | $12M | $7M | $121.9K | |
| Net Change in Cash | $-674.5K | $1M | $2M | $1M | |
| Taxes Paid | $564.8K | $205.4K | $142.7K | $47.4K | |
| Free Cash Flow | $-4M | $-1M | $3M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 29.2% | 40.4% | 34.2% | · | |
| Operating Margin | 2.9% | 15.5% | 14.5% | · | |
| Net Margin | 5.8% | 15.6% | 14.5% | · | |
| Pretax Margin | 7.7% | 17.8% | 16.2% | · | |
| EBITDA Margin | 4.1% | 16.5% | 15.6% | · | |
| ROA | 2.4% | 9.3% | 10.7% | · | |
| ROE | 4.1% | 13.9% | 14.7% | · | |
| ROIC | 1.1% | 7.4% | 10.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.5 | 3.5 | · | |
| Quick Ratio | 1.5 | 1.9 | 1.5 | · | |
| Debt / Equity | 0.6 | 0.4 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.6 | 0.7 | · | |
| Inventory Turnover | 2.9 | 2.7 | 2.2 | · | |
| Receivables Turnover | 3.5 | 5.1 | 5.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.19 | $0.18 | $0.15 | · | |
| Revenue / Share | $0.13 | $0.15 | $0.14 | · | |
| Cash Flow / Share | $0.02 | $-0.01 | $0.02 | · | |
| Cash / Share | $0.05 | $0.05 | · | · | |
| EPS (TTM) | $0.01 | $0.02 | $0.02 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $21M | $24M | $20M | · | |
| Net Income TTM | $1M | $4M | $3M | · | |
| Market Cap | $88M | $421M | $182M | · | |
| Enterprise Value | $78M | $406M | · | · | |
| P/E | 56.5 | 134.5 | 58.5 | · | |
| P/S | 4.3 | 17.9 | 9.2 | · | |
| P/B | 3.0 | 14.6 | 7.6 | · | |
| P / Tangible Book | 3.1 | 15.2 | 7.7 | · | |
| P / Cash Flow | 30.5 | -348.8 | 58.7 | · | |
| P / FCF | -23.7 | -311.4 | 61.0 | · | |
| EV / EBITDA | 91.2 | 104.6 | · | · | |
| EV / FCF | -20.8 | -300.0 | · | · | |
| EV / Revenue | 3.8 | 17.3 | · | · | |
| Earnings Yield | 1.8% | 0.74% | 1.7% | · |
Per Share
| Metric | Trend | Q4 2024 |
|---|---|---|
| EPS (TTM) | $0.02 |
Valuation (TTM)
| Metric | Trend | Q4 2024 |
|---|---|---|
| Revenue TTM | $24M | |
| Net Income TTM | $4M | |
| P/E | 134.5 | |
| Earnings Yield | 0.74% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Revenue | $21M | $24M | $20M | $19M | $21M |
| Gross Margin % | 29.2% | 40.4% | 34.2% | · | · |
| Operating Margin % | 2.9% | 15.5% | 14.5% | · | · |
| Net Income | $1M | $4M | $3M | $3M | $3M |
| Diluted EPS | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Debt / Equity | 0.6 | 0.4 | · | · | · |
| Current Ratio | 1.9 | 2.5 | 3.5 | · | · |
| Quick Ratio | 1.5 | 1.9 | 1.5 | · | · |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-4M | $-1M | $3M | · | · |
Institutional owners (13F)
Institutional activity — Q4 2025 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (+2 vs prior Q) | 3 (-3 vs prior Q) | 2 (0 vs prior Q) | 2 (-1 vs prior Q) | +178K |
Compared to Q3 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Erqi Wang, JOLLY HARMONY ENTERPRISES Ltd | Sept. 25, 2026 | 3.35% | Amendment | · | SEC |
| Er Pu International Ltd, JOLLY HARMONY ENTERPRISES Ltd, Wang Erqi | Aug. 21, 2026 | 6.77% | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ZJYL | $88M | 56.5 | · | 5.8% | 4.1% | 29.2% |
| BDMD | $42M | -1.4 | · | -121.0% | -76.8% | 83.8% |
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Feb 10, 2026